| scholarly article | Q13442814 |
| P50 | author | Hermann Haller | Q56955546 |
| P2093 | author name string | Jan T Kielstein | |
| Danilo Fliser | |||
| Robert Faulhaber-Walter | |||
| Philipp Kümpers | |||
| Sascha David | |||
| Carsten Hafer | |||
| Alexander Lukasz | |||
| Rüdiger Horn | |||
| P2860 | cites work | Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators | Q42504250 |
| Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies | Q42655578 | ||
| The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies | Q44771602 | ||
| The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism | Q45248496 | ||
| Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma? | Q45979392 | ||
| Regulation of angiopoietin expression by bacterial lipopolysaccharide. | Q46725976 | ||
| Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation | Q46931416 | ||
| VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development | Q47741437 | ||
| Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. | Q48015897 | ||
| Protective role of angiopoietin-1 in endotoxic shock | Q50782917 | ||
| Vascular endothelial growth factor in severe sepsis and septic shock | Q56784482 | ||
| Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway | Q73333644 | ||
| Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway | Q73586047 | ||
| Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients | Q81468897 | ||
| Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability | Q81551352 | ||
| Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation | Q22004269 | ||
| Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning | Q24310148 | ||
| Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality | Q24676668 | ||
| Bench-to-bedside review: sepsis is a disease of the microcirculation | Q24800640 | ||
| Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans | Q25255098 | ||
| Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network | Q27861021 | ||
| Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells | Q28203283 | ||
| Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats | Q28214611 | ||
| Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia | Q28344343 | ||
| Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 | Q28513759 | ||
| Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1 | Q28757126 | ||
| APACHE II: a severity of disease classification system | Q29547729 | ||
| The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine | Q29618869 | ||
| Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome | Q33682542 | ||
| Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo | Q34037478 | ||
| Mechanisms of sepsis-induced organ dysfunction | Q34703764 | ||
| The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome | Q35051545 | ||
| Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells | Q35070344 | ||
| 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. | Q35094247 | ||
| Pulmonary artery catheter versus pulse contour analysis: a prospective epidemiological study | Q35629946 | ||
| Endothelium as an organ system | Q35760637 | ||
| Pulmonary endothelium in acute lung injury: from basic science to the critically ill. | Q35838918 | ||
| Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation | Q36380942 | ||
| Angiopoietins: a link between angiogenesis and inflammation. | Q36625591 | ||
| Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays | Q36955225 | ||
| Admission angiopoietin levels in children with septic shock. | Q37367802 | ||
| A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis | Q37735839 | ||
| Hypoxic regulation of angiopoietin-2 expression in endothelial cells. | Q38346353 | ||
| Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway | Q38525872 | ||
| Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution | Q40767929 | ||
| Angiopoietin-1 protects the adult vasculature against plasma leakage. | Q40890338 | ||
| P433 | issue | 6 | |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | R147 | |
| P577 | publication date | 2008-11-21 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients | |
| P478 | volume | 12 |
| Q33752686 | A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia |
| Q46622856 | Aerobic training and angiogenesis activation in patients with stable chronic heart failure: a preliminary report |
| Q47701304 | An Update on Host-Pathogen Interplay and Modulation of Immune Responses during Orientia tsutsugamushi Infection. |
| Q89571786 | Angiopoietin 2 Levels in the Risk Stratification and Mortality Outcome Prediction of Sepsis-Associated Coagulopathy |
| Q57042117 | Angiopoietin Level Trajectories in Toddlers with Severe Sepsis and Septic Shock and Their Effect on Capillary Endothelium |
| Q33430515 | Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli |
| Q33913118 | Angiopoietin-1 is associated with cerebral vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage |
| Q41691907 | Angiopoietin-2 Levels as Predictors of Outcome in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome. |
| Q44001139 | Angiopoietin-2 and outcome in patients with acute decompensated heart failure |
| Q38404683 | Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock--a biomarker substudy of the IABP-SHOCK II-Trial |
| Q44354947 | Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome |
| Q34024826 | Angiopoietin-2 is a potential mediator of endothelial barrier dysfunction following cardiopulmonary bypass |
| Q34026850 | Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity |
| Q85049840 | Angiopoietin-2 levels predict mortality in CKD patients |
| Q36994658 | Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis* |
| Q38379274 | Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation |
| Q34451437 | Angiopoietins, abdominal aortic aneurysm and atherosclerosis |
| Q34287310 | Association of angiopoietin-2 with renal outcome in chronic kidney disease |
| Q37713182 | Biomarkers of endothelial activation/dysfunction in infectious diseases |
| Q37858113 | Biomarkers: The Future |
| Q36205459 | Circulating Angiopoietin-2 and Its Soluble Receptor Tie-2 Concentrations Are Related to Renal Function in Two Population-Based Cohorts |
| Q45959076 | Circulating Angiopoietin-2 levels predict mortality in kidney transplant recipients: a 4-year prospective case-cohort study. |
| Q89644187 | Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies |
| Q28732725 | Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis |
| Q37305274 | Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality |
| Q43152652 | Circulating angiopoietin-2 levels increase with progress of chronic kidney disease |
| Q45254504 | Circulating angiopoietins and cardiovascular mortality in cardiogenic shock |
| Q48140426 | Circulating angiopoietins in idiopathic pulmonary arterial hypertension |
| Q46211892 | Circulating angiopoietin‐2, its soluble receptor Tie‐2, and mortality in the general population |
| Q38056387 | Clinical application of sepsis biomarkers |
| Q59340499 | Clinical characteristics and prognosis of serous body cavity effusions in patients with sepsis: a retrospective observational study |
| Q26823450 | Clinical utility of biomarkers of endothelial activation in sepsis--a systematic review |
| Q40312655 | Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins |
| Q42420252 | Does low angiopoietin-1 predict adverse outcome in sepsis? |
| Q35597977 | Drug Repurposing Screen Identifies Foxo1-Dependent Angiopoietin-2 Regulation in Sepsis. |
| Q33408673 | Dysregulation of angiopoietin 1 and 2 in Escherichia coli O157:H7 infection and the hemolytic-uremic syndrome |
| Q38105018 | Dysregulation of the angiopoietin–Tie-2 axis in sepsis and ARDS |
| Q34031862 | Early changes of plasma angiopoietin-2 in patients with multiple trauma |
| Q33850993 | Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality |
| Q38122283 | Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction |
| Q54217602 | Endothelial Activation: The Ang/Tie Axis in Sepsis |
| Q92365798 | Endothelial Dysfunction Is Associated with Mortality and Severity of Coagulopathy in Patients with Sepsis and Disseminated Intravascular Coagulation |
| Q40363013 | Endothelial Permeability and Hemostasis in Septic Shock: Results From the ProCESS Trial |
| Q38270705 | Endothelial barrier dysfunction in septic shock |
| Q88723373 | Endothelial dysfunction following coronary artery bypass grafting : Influence of patient and procedural factors |
| Q40331822 | Endovascular cooling and endothelial activation in hemorrhagic stroke patients |
| Q90696561 | Evaluation of plasma angiopoietin-2 and vascular endothelial growth factor in healthy dogs and dogs with systemic inflammatory response syndrome or sepsis |
| Q37206670 | Excess circulating angiopoietin-2 levels in sepsis: harbinger of death in the intensive care unit? |
| Q36902680 | Fixing the leak: targeting the vascular endothelium in sepsis. |
| Q37690230 | Flunarizine suppresses endothelial Angiopoietin-2 in a calcium - dependent fashion in sepsis |
| Q21261838 | Imbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropenia |
| Q85228111 | Is angiopoietin-2 the key piece in the sepsis puzzle?* |
| Q27027585 | Mending Leaky Blood Vessels: The Angiopoietin-Tie2 Pathway in Sepsis |
| Q59798557 | Non-neutralizing antibodies increase endogenous circulating Ang1 levels |
| Q64054016 | Prognostic value of endothelial biomarkers in refractory cardiogenic shock with ECLS: a prospective monocentric study |
| Q33564598 | Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. |
| Q36773889 | Ratio of angiopoietin-2 to angiopoietin-1 predicts mortality in acute lung injury induced by paraquat |
| Q37288661 | Role of angiopoietin/tie2 in critical illness: promising biomarker, disease mediator, and therapeutic target? |
| Q36454207 | Selective V1aagonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis |
| Q54600065 | Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure. |
| Q38688341 | The Angiopoietin-Tie2 Signaling Axis in Systemic Inflammation |
| Q92922234 | The Difference of Angiopoietin-2 Levels between Dengue Hemorrhagic Fever Patients with Shock and without Shock |
| Q28072373 | The Endothelial Glycocalyx: New Diagnostic and Therapeutic Approaches in Sepsis |
| Q33751755 | The angiogenic factors and their soluble receptors in sepsis: friend, foe, or both? |
| Q38120355 | The angiopoietin:Tie 2 interaction: A potential target for future therapies in human vascular disease |
| Q44309209 | The dynamics of angiogenic factors and their soluble receptors in relation to organ dysfunction in disseminated intravascular coagulation associated with sepsis |
| Q40688893 | The renal angiopoietin/Tie2 system in lethal human sepsis |
| Q36616721 | The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS) associated with critical illness |
| Q34026872 | The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children |
| Q42018928 | The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis |
| Q37626268 | The temporal kinetics of circulating angiopoietin levels in children with sepsis |
| Q37279750 | Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis |
| Q34677335 | Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study |
| Q36641448 | Transcriptomic analysis of the stress response to weaning at housing in bovine leukocytes using RNA-seq technology |
| Q42517486 | Vascular Endothelial Dysfunction during Cardiac Surgery: On-Pump versus Off-Pump Coronary Surgery |
| Q40269339 | Ventilator-induced lung injury increases expression of endothelial inflammatory mediators in the kidney |
| Q37626881 | Year in review 2008: Critical Care--sepsis |
| Q54455327 | [Angiopoietin-2: prognostic parameter in cardiogenic shock]. |
Search more.